Analyzing...
Loading company...
Nothing flagged for monitoring
“Operates in Chemicals — Specialty & Commodity.”
₹650 Cr revenue.
COGS 51.2%, employees 10.3%.
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 7.6%▼ | 7.6% |
| ROCE | 9.6%▼ | 10.9% |
| Net Margin | 8.8%▲ | 5.1% |
| EBITDA Margin | 20.4%▲ | 12.1% |
| Debt To Equity | 0.03x▼ | 0.20x |
| Rev Growth 3yr | 2.6%▼ | 5.9% |
| EPS Growth 3yr | -9.3%▲ | -9.4% |
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹638 Cr -1.8% | ₹650 Cr +12.1% | ₹580 Cr -29.9% | ₹827 Cr +38.0% | ₹599 Cr +76.5% | ₹339 Cr -40.0% | ₹566 Cr -4.9% | ₹595 Cr |
| Other Income | ₹28 Cr -2.6% | ₹29 Cr +14.1% | ₹25 Cr +41.3% | ₹18 Cr -37.3% | ₹28 Cr +64.4% | ₹17 Cr -0.7% | ₹17 Cr -2.3% | ₹18 Cr |
| Total Income | ₹666 Cr -1.8% | ₹679 Cr +12.2% | ₹605 Cr -28.4% | ₹845 Cr +34.6% | ₹627 Cr +75.9% | ₹357 Cr -38.8% | ₹583 Cr -4.8% | ₹612 Cr |
| COGS | ₹304 Cr -8.7% | ₹332 Cr +15.7% | ₹287 Cr -34.4% | ₹438 Cr +39.2% | ₹315 Cr +93.6% | ₹163 Cr -37.6% | ₹260 Cr -13.5% | ₹301 Cr |
| ₹589 Cr -4.5% | ₹617 Cr +12.3% | ₹549 Cr -25.0% | ₹732 Cr +34.7% | ₹543 Cr +64.1% | ₹331 Cr -32.4% | ₹490 Cr -4.2% | ₹511 Cr | |
| Profit Before Tax | ₹77 Cr +24.7% | ₹62 Cr +11.1% | ₹56 Cr -50.8% | ₹113 Cr +33.9% | ₹84 Cr +230.0% | ₹26 Cr -72.7% | ₹94 Cr -7.7% | ₹101 Cr |
| ₹19 Cr +43.7% | ₹13 Cr -23.8% | ₹17 Cr -42.2% | ₹29 Cr +55.6% | ₹19 Cr +744.9% | ₹2 Cr -89.2% | ₹21 Cr -42.2% | ₹36 Cr | |
| Net Profit | ₹58 Cr +19.7% | ₹49 Cr +26.4% | ₹39 Cr -53.8% | ₹83 Cr +27.6% | ₹65 Cr +180.7% | ₹23 Cr -68.1% | ₹73 Cr +11.0% | ₹66 Cr |
| Profit (Owners) | ₹58 Cr +19.7% | ₹49 Cr +26.4% | ₹39 Cr -53.8% | ₹83 Cr +27.6% | ₹65 Cr +180.7% | ₹23 Cr -68.1% | ₹73 Cr +11.0% | ₹66 Cr |
| Other Comprehensive Income | (₹33 Cr) ↓ Decline | ₹31 Cr -51.2% | ₹64 Cr +102.2% | ₹31 Cr -27.4% | ₹43 Cr +122.5% | ₹19 Cr ↑ Recovery | (₹26 Cr) ↓ Decline | ₹5 Cr |
| EPS | ₹104.41 | ₹87.26 | ₹69.03 | ₹149.45 | ₹117.09 | ₹41.71 | ₹130.60 | ₹117.70 |
| Diluted Shares | ₹0.56 Cr | ₹0.56 Cr | ₹0.56 Cr | ₹0.56 Cr | ₹0.56 Cr | ₹0.56 Cr | ₹0.56 Cr | ₹0.56 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Intimation of Closure of Trading Window
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dipkanti Investments & Financing Pvt Ltd
The Company wish to inform you that application has been made to BSE for reclassification of Promoter to Public.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vishwa A Shroff
Investor Presentation for the month of February, 2026.
Seeking approval for reclassification under Regulation 31A of SEBI LODR Regulations, 2015.
Reclassification application under Regulation 31A(8) of SEBI LODR Regulations, 2015.
Unaudited Results for the quarter ended 31.12.2025
Reclassification application by a Promoter under Regulation 31A of SEBI LODR Regulations, 2015.
Transpek Industry Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2026 ,inter alia, to consider and approve Unaudited Financial Results .... Transp...
Compliance Certificare under Regulation 74(5) of SEBI (DP) Regulations, 2018.
Notice for Closure of Trading Window for the quarter ended 31.12.2025.
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashwin Shroff
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashwin Shroff
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shruti Shroff
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.